These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20508384)

  • 1. The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients.
    Ishii A; Imanishi Y; Kurajoh M; Nagata Y; Kobayashi K; Miki T; Inaba M; Nishizawa Y
    Endocr J; 2010; 57(7):609-14. PubMed ID: 20508384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
    Kanatani M; Sugimoto T; Kaji H; Ikeda K; Chihara K
    Eur J Endocrinol; 2001 Mar; 144(3):263-9. PubMed ID: 11248746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I.
    Hatakeyama Y; Mizunashi K; Furukawa Y; Yabuki S; Sato Y; Igarashi T
    J Clin Endocrinol Metab; 2003 May; 88(5):2250-5. PubMed ID: 12727982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Goto MM; Abe K
    Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
    J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency.
    Allgrove J; Chayen J; Jayaweera P; O'Riordan JL
    Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Difference in the therapeutic response to active vitamin D3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism].
    Inoue D
    Clin Calcium; 2007 Aug; 17(8):1255-61. PubMed ID: 17660624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum osteocalcin concentration in a patient with pseudohypoparathyroidism type Ib].
    Ichikawa T; Abe Y; Kanamori A; Yajima Y
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):775-84. PubMed ID: 1889514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of baseline level/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism.
    Mizunashi K; Furukawa Y; Goto MM
    Calcif Tissue Int; 1998 Feb; 62(2):99-103. PubMed ID: 9437041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cholecalciferol and calcitriol on biochemical bone markers in HIV type 1-infected males: results of a clinical trial.
    Bang UC; Kolte L; Hitz M; Schierbeck LL; Nielsen SD; Benfield T; Jensen JE
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):658-64. PubMed ID: 23199009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients.
    Björkman M; Sorva A; Risteli J; Tilvis R
    Age Ageing; 2008 Jan; 37(1):25-31. PubMed ID: 17965037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism.
    Suarez F; Lebrun JJ; Lecossier D; Escoubet B; Coureau C; Silve C
    J Clin Endocrinol Metab; 1995 Mar; 80(3):965-70. PubMed ID: 7883858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency in two young adults with biochemical findings resembling pseudohypoparathyroidism type I and type II.
    Seki T; Yamamoto M; Kimura H; Tsuiki M; Ono M; Miki N; Takano K; Sato K
    Endocr J; 2010; 57(8):735-44. PubMed ID: 20505259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis.
    Shiraishi A; Higashi S; Ohkawa H; Kubodera N; Hirasawa T; Ezawa I; Ikeda K; Ogata E
    Calcif Tissue Int; 1999 Oct; 65(4):311-6. PubMed ID: 10485984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of pseudohypoparathyroidism in adolescent boys.
    Kabícek P; Kutílek S; Bayer M; Stĕpán JJ
    Acta Univ Carol Med (Praha); 1994; 40(1-4):53-6. PubMed ID: 9355673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.